Tagged: rocheposay

Sales of Ocrevus have been 26% greater at $4.7 billion though Perjeta sales had been $4.2 billion, an boost of 19%, mostly due to growth in China. Kadcyla sales grew by 35% to $1.9 billion mostly due to larger demand in each the...